Literature DB >> 8844967

Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers.

P Rogalla1, C Rohen, U Bonk, J Bullerdiek.   

Abstract

The mean telomeric repeat fragment (TRF) lengths of 85 breast cancer samples were determined. The TRF length varied between 7260 bp and 14570 bp (average 11370 bp) reflecting a unimodal distribution. There was no significant correlation between TRF length and the histological grade of the tumor. Neither were there differences in telomeric length between different histological types of tumors, in particular lobular and ductal types, nor correlations between TRF length and age of patient, tumor volume, lymph node status, or steroid receptor status. These results contradict the hypothesis that the telomere repeat fragment sizes represent limiting or promoting factors for the growth of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844967     DOI: 10.1016/0304-3835(96)04304-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Elevated TRF2 in advanced breast cancers with short telomeres.

Authors:  Malissa C Diehl; Michael O Idowu; Katherine N Kimmelshue; Timothy P York; Colleen K Jackson-Cook; Kristi C Turner; Shawn E Holt; Lynne W Elmore
Journal:  Breast Cancer Res Treat       Date:  2010-07-13       Impact factor: 4.872

Review 2.  Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation?

Authors:  Alan K Meeker; Pedram Argani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

3.  Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer.

Authors:  Fariborz Rashid-Kolvear; Melania Pintilie; Susan J Done
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

4.  Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma.

Authors:  Alan K Meeker; Jessica L Hicks; Edward Gabrielson; William M Strauss; Angelo M De Marzo; Pedram Argani
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 5.  Telomeres and telomerase in endocrine pathology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

Review 6.  The potential utility of telomere-related markers for cancer diagnosis.

Authors:  Christopher M Heaphy; Alan K Meeker
Journal:  J Cell Mol Med       Date:  2011-06       Impact factor: 5.310

7.  Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.

Authors:  Kaori Saito; Atsuhito Yagihashi; Shunichi Nasu; Yoko Izawa; Masashi Nakamura; Daisuke Kobayashi; Naoki Tsuji; Naoki Watanabe
Journal:  Jpn J Cancer Res       Date:  2002-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.